Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126365701 | 12636570 | 1 | I | 20160520 | 20160801 | 20160809 | 20160809 | EXP | FR-MYLANLABS-2016M1032962 | MYLAN | 0.00 | Y | 0.00000 | 20160809 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126365701 | 12636570 | 1 | PS | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | Intravenous (not otherwise specified) | 4 G, QD | U | U | 65458 | 4 | G | POWDER FOR SOLUTION FOR INFUSION | QD | ||||
| 126365701 | 12636570 | 2 | SS | VIDAZA | AZACITIDINE | 1 | Subcutaneous | 56 MG, BID | U | U | 0 | 56 | MG | BID | |||||
| 126365701 | 12636570 | 3 | SS | ZAMUDOL | TRAMADOL HYDROCHLORIDE | 1 | 1 DF, BID | Y | U | 0 | 1 | DF | BID | ||||||
| 126365701 | 12636570 | 4 | SS | OROZAMUDOL | TRAMADOL | 1 | 1 TO 3 TIMES A DAY | Y | U | 0 | ORODISPERSIBLE TABLET | QD | |||||||
| 126365701 | 12636570 | 5 | SS | INEXIUM /01479302/ | ESOMEPRAZOLE MAGNESIUM | 1 | 20 MG, QD | Y | U | 0 | 20 | MG | TABLET | QD | |||||
| 126365701 | 12636570 | 6 | SS | IMOVANE | ZOPICLONE | 1 | Oral | 1 DF, QD | Y | U | 0 | 1 | DF | FILM-COATED TABLET | QD | ||||
| 126365701 | 12636570 | 7 | C | BISOPROLOL HEMIFUMARATE | BISOPROLOL FUMARATE | 1 | 2.5, ONCE DAILY | 0 | QD | ||||||||||
| 126365701 | 12636570 | 8 | C | LERCAN | LERCANIDIPINE | 1 | 10 MG, QD | 0 | 10 | MG | QD | ||||||||
| 126365701 | 12636570 | 9 | C | DUPHALAC | LACTULOSE | 1 | 0 | ||||||||||||
| 126365701 | 12636570 | 10 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | 20 MG, QD | 0 | 20 | MG | QD | ||||||||
| 126365701 | 12636570 | 11 | C | PERFALGAN | ACETAMINOPHEN | 1 | 1 G, QID | 0 | 1 | G | QID | ||||||||
| 126365701 | 12636570 | 12 | C | GAVISCON /00237601/ | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | 2 DF, QD | 0 | 2 | DF | QD | ||||||||
| 126365701 | 12636570 | 13 | C | LASILIX FAIBLE | FUROSEMIDE | 1 | 3 DF, QD | 0 | 3 | DF | TABLET | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126365701 | 12636570 | 1 | Product used for unknown indication |
| 126365701 | 12636570 | 2 | Acute myeloid leukaemia |
| 126365701 | 12636570 | 3 | Product used for unknown indication |
| 126365701 | 12636570 | 4 | Product used for unknown indication |
| 126365701 | 12636570 | 5 | Product used for unknown indication |
| 126365701 | 12636570 | 6 | Product used for unknown indication |
| 126365701 | 12636570 | 7 | Product used for unknown indication |
| 126365701 | 12636570 | 8 | Product used for unknown indication |
| 126365701 | 12636570 | 9 | Product used for unknown indication |
| 126365701 | 12636570 | 10 | Product used for unknown indication |
| 126365701 | 12636570 | 11 | Product used for unknown indication |
| 126365701 | 12636570 | 12 | Product used for unknown indication |
| 126365701 | 12636570 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126365701 | 12636570 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126365701 | 12636570 | Anaphylactic reaction | |
| 126365701 | 12636570 | Anuria | |
| 126365701 | 12636570 | Arrhythmia | |
| 126365701 | 12636570 | Circulatory collapse | |
| 126365701 | 12636570 | Febrile bone marrow aplasia | |
| 126365701 | 12636570 | Haemosiderosis | |
| 126365701 | 12636570 | Hypoxia | |
| 126365701 | 12636570 | Lung disorder | |
| 126365701 | 12636570 | Myelofibrosis | |
| 126365701 | 12636570 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126365701 | 12636570 | 3 | 20160521 | 0 | ||
| 126365701 | 12636570 | 4 | 20160521 | 0 | ||
| 126365701 | 12636570 | 5 | 20160521 | 0 | ||
| 126365701 | 12636570 | 6 | 20160521 | 0 |